These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 9927187

  • 1. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
    Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R.
    Oncogene; 1999 Jan 14; 18(2):305-14. PubMed ID: 9927187
    [Abstract] [Full Text] [Related]

  • 2. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 Jan 14; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 8. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
    Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN.
    Cancer Res; 1998 Jan 15; 58(2):362-6. PubMed ID: 9443418
    [Abstract] [Full Text] [Related]

  • 11. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P.
    Carcinogenesis; 2004 Dec 15; 25(12):2303-10. PubMed ID: 15358633
    [Abstract] [Full Text] [Related]

  • 12. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL.
    Cancer Res; 1999 May 01; 59(9):2223-8. PubMed ID: 10232612
    [Abstract] [Full Text] [Related]

  • 13. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
    Graus-Porta D, Beerli RR, Daly JM, Hynes NE.
    EMBO J; 1997 Apr 01; 16(7):1647-55. PubMed ID: 9130710
    [Abstract] [Full Text] [Related]

  • 14. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
    Liu CY, Lai YY, Lo CJ.
    J Surg Res; 2004 Apr 01; 117(2):223-31. PubMed ID: 15047127
    [Abstract] [Full Text] [Related]

  • 15. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor.
    Slice LW, Hodikian R, Zhukova E.
    J Cell Physiol; 2003 Sep 01; 196(3):454-63. PubMed ID: 12891702
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM.
    Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 18. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 19. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M.
    Anticancer Res; 2003 Dec 15; 23(1A):245-9. PubMed ID: 12680220
    [Abstract] [Full Text] [Related]

  • 20. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.